相关实验视频
Updated: Jul 29, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
7.2K
胰腺固体伪皮质瘤的深度蛋白质基因特征揭示了与其他胰腺瘤不同的独特特征
Atsushi Tanaka1,2,3,4, Yusuke Otani5,6, David S Klimstra7,8
1Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. atanaka@bidmc.harvard.edu.
Biomarker research
|November 28, 2025
概括
固体伪皮质瘤 (SPN) 蛋白质分析揭示了独特的特征,包括丰富的溶酶体蛋白和与其他胰腺癌相比不同的代谢途径. 这项研究提供了对SPN生物学和潜在的向治疗方法的见解.
科学领域:
- 在瘤学瘤学.
- 蛋白质组学是指蛋白质组学.
- 分子生物学分子生物学
背景情况:
- 固体伪毛囊瘤 (SPN) 是一种罕见的胰腺瘤,生物学不明.
- 现有的知识缺口存在,特别是在蛋白质层面,阻碍了有效的治疗策略.
研究的目的:
- 进行SPN的全面蛋白质组分析.
- 为了区分SPN蛋白质组与胰腺管腺癌 (PDAC) 和神经内分泌瘤 (NET).
- 确定SPN的潜在治疗点.
主要方法:
- 对13个SPN样本进行基于质谱的蛋白质组分析.
- 对11个PDAC和10个NET样本进行比较蛋白质组分析.
- 代谢途径和受体氨酸激酶 (RTK) 信号的分析.
主要成果:
- SPN表现出一个独特的蛋白质组,与PDAC和NET不同.
- 与溶解体相关的蛋白质被丰富,MITF和TFE3过度表达.
- SPN 呈现较高的脂肪酸氧化,较低的糖解,高的蛋白质酶活性,并且具有免疫感冒 (低MHC I 类).
- 确定PDGFRA和ERBB2 (HER2) 是潜在的治疗点.
结论:
- SPN的蛋白质基因格局与其他胰腺瘤有显著差异.
- 过度表达的MITF和TFE3表明 lysosomal 途径参与了SPN 病变发生.
- 代谢适应和免疫冷变型为SPN行为提供了洞察力.
- 准PDGFRA和ERBB2可能是SPN的有希望的治疗途径.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...